John Harrahy

John Harrahy is a Senior Director in the Genomic Medicine Unit at Sanofi, where they currently lead bioanalytical efforts. With a strong background in analytical process development, John previously held the role of Director of Process Development at Amgen, overseeing a significant team and supporting late-stage CMC process development. Their past experience includes serving as Associate Director of Bioanalytical Development at Genzyme, where they led projects crucial for enzyme replacement therapies. John began their career as a post-doc at Beth Israel Deaconess and holds a Bachelor’s degree in Biochemistry from the University of New Hampshire and a PhD in Biochemistry and Biophysics from Oregon State University.